Ullet index:TAIKO PHARMACEUTICAL CO.,LTD.:4574

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index TAIKO PHARMACEUTICAL CO.,LTD. Go to web site 4574 Medicals 東証プライム December 1, 2000 2009.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

TAIKO PHARMACEUTICAL CO.,LTD. mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 March 31, 2020
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 6,739
plusdown
8,044
plusdown
12,807
plusdown
22,781
plusup
19,374
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp -3,610
plusup
-4,894
plusup
-9,593
plusdown
3,852
plusup
2,453
plus
Operating Cash Flow(OFC)Help -307
plusup
-1,993
plusdown
-1,596
plusdown
-1,517
plusdown
3,493
plus
Free Cash Flow(FCF)Help 859
plusup
-1,803
plusup
-3,218
plusup
-4,277
plusdown
3,045
plus
OFC - Net IncomeHelp 42
plusup
21
plusdown
29
plusdown
70
plusdown
71
plus
Current AssetsHelp - - - - -
FCF / Current AssetsHelp -6.60%
plusup
-60.49%
plusdown
-20.28%
plusdown
-13.90%
plusdown
33.15%
plus
Current Assets / Amount of SalesHelp 75.96%
plusup
65.38%
plusdown
69.64%
plusup
62.05%
plusdown
70.40%
plus
Free Cash Revenue RatioHelp 14.04%
plusup
-35.77%
plusdown
-28.48%
plusdown
-24.32%
plusdown
20.34%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

TAIKO PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

Nxera Pharma Co., Ltd.
CHUGAI PHARMACEUTICAL CO., LTD.
Eisai Co.,Ltd.
Nissui Pharmaceutical Co.,Ltd.
TORII PHARMACEUTICAL CO.,LTD.
NANO MRNA Co., Ltd.
K Pharma,Inc.
TSUMURA & CO.
Otsuka Holdings Co.,Ltd.
Noile-Immune Biotech Inc.